Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: ICH MedDRA Management Committee | Statement: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, hasBody, ICH MedDRA Management Committee]

Target entity: ICH MedDRA Management Committee
Context triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, hasBody, ICH MedDRA Management Committee]

• A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
  The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
• B. SNOMED International
  SNOMED International is a global not-for-profit organization responsible for developing and promoting the SNOMED CT clinical terminology standard used in healthcare systems worldwide.
• C. Pharmacovigilance Risk Assessment Committee
  The Pharmacovigilance Risk Assessment Committee is a scientific body responsible for evaluating and monitoring the safety of human medicines and advising on risk management measures in the European Union.
• D. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• E. Committee for Orphan Medicinal Products
  The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: ICH MedDRA Management Committee
Triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, hasBody, ICH MedDRA Management Committee]

The ICH MedDRA Management Committee is the governing body responsible for overseeing the development, maintenance, and implementation of the MedDRA medical terminology used for regulatory communication in pharmaceuticals.

Target entity: ICH MedDRA Management Committee
Target entity description: The ICH MedDRA Management Committee is the governing body responsible for overseeing the development, maintenance, and implementation of the MedDRA medical terminology used for regulatory communication in pharmaceuticals.

• A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use chosen
  The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
• B. SNOMED International
  SNOMED International is a global not-for-profit organization responsible for developing and promoting the SNOMED CT clinical terminology standard used in healthcare systems worldwide.
• C. Pharmacovigilance Risk Assessment Committee
  The Pharmacovigilance Risk Assessment Committee is a scientific body responsible for evaluating and monitoring the safety of human medicines and advising on risk management measures in the European Union.
• D. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• E. Committee for Orphan Medicinal Products
  The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
• F. None of above.